DelistingMay 15, 2026, 04:07 PM
Skye Bioscience Notifies Nasdaq Non-Compliance; Equity $9.01M vs $10M Min
AI Summary
Skye Bioscience, Inc. received a written notification from Nasdaq regarding non-compliance with the Nasdaq Global Market's minimum stockholders' equity standard. The company's stockholders' equity was $9,011,804, falling short of the required $10,000,000. Skye has 45 calendar days to submit a plan to regain compliance, with a potential extension of up to 180 days if the plan is accepted. The notice does not immediately affect the listing or trading of the company's common stock.
Key Highlights
- Skye Bioscience received a Nasdaq notice for non-compliance with Listing Rule 5450(b)(1)(A).
- The company's stockholders' equity was $9,011,804 as of March 31, 2026.
- Nasdaq Global Market requires a minimum stockholders' equity of $10,000,000.
- Skye has 45 calendar days, until June 29, 2026, to submit a plan to regain compliance.
- If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days, until November 9, 2026.
- The notice has no immediate effect on the listing or trading of the company's common stock.
Price Impact
More from SKYE